Oligofructose-enriched inulin improves some inflammatory markers and metabolic endotoxemia in women with type 2 diabetes mellitus: a randomized controlled clinical trial.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Anti-inflammatory therapeutic approaches are considered for the management of type 2 diabetes and for the prevention of its complications. There is limited evidence regarding the effects of prebiotics on inflammation, especially in patients with type 2 diabetes. This trial aims to examine the effects of oligofructose-enriched inulin on glycemic status, inflammation markers, and metabolic endotoxemia in female patients.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Nutrition

Title: Nutrition (Burbank, Los Angeles County, Calif.)

Publisher: Elsevier BV

ISSN (Electronic): 1873-1244

ISSN (Print): 0899-9007

Publication date (Electronic): Apr 2014

Volume: 30

Issue: 4

Affiliations

[1 ] Student Research Center, Faculty of Nutrition, Tabriz University of Medical Sciences, Tabriz, Iran.

[2 ] Department of Biochemistry and Diet Therapy, Nutrition Research Center, Faculty of Nutrition, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: bahrampg@yahoo.com.

[3 ] Medical Education Research Center, Department of Statistics and Epidemiology, Faculty of Health, Tabriz University of Medical Sciences, Tabriz, Iran.

Article

Publisher Item ID: S0899-9007(13)00404-8

DOI: 10.1016/j.nut.2013.09.005

PubMed ID: 24332524

SO-VID: 37537e8f-4d1b-4069-9cac-05be1655a1fe

History

Keywords: Interleukin,Lipopolysaccharide,Prebiotics,Tumor necrosis factor-α

Data availability:

Keywords: Interleukin, Lipopolysaccharide, Prebiotics, Tumor necrosis factor-α

Comments

Comment on this article

scite_

Cited by 65

See all cited by

- Version 1